Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 50

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 50
---
some cases, patent prosecution of our licensed technology may be controlled solely by the licensor. If our licensors fail to obtain and
maintain patent or other protection for the proprietary intellectual property we license from them, we could lose our rights to the intellectual
property or our exclusivity with respect to those rights, and our competitors could market competing products using the intellectual
property. In certain cases, we may control the prosecution of patents resulting from licensed technology. In the event we breach any
of our obligations related to such prosecution, we may incur significant liability to our licensing partners. If disputes over intellectual
property and other rights that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable
terms, we may be unable to successfully develop and commercialize the affected product candidates.

We
have no patent protection for MIRA-55, which could adversely impact MIRA-55’s potential competitive position.

We
have no issued patents relating to MIRA-55 and our patent application for MIRA-55 may not result in an issued patent. While we attempt
to protect our proprietary information as trade secrets through certain agreements with our employees, consultants, agents and other
organizations to which we disclose our proprietary information, we cannot give assurance that these agreements will provide effective
protection for our proprietary information in the event of unauthorized use or disclosure of such information. If other products similar
to MIRA-55 are approved and marketed, we may be unable to prevent them from competing with MIRA-55 in MIRA-55’s potential marketplace.
We expect that the presence of one or more competing products could reduce our potential market share and could negatively impact potential
price levels and third-party reimbursement for MIRA-55, any of which would materially affect our business.

50

Risks
Relating to the Ownership of our Common Stock

Because
of the speculative nature of investment risk, you may lose your entire investment.

An
investment in our securities carries a high degree of risk and should be considered as a speculative investment. We have a limited operating
history, no revenues, have not paid dividends, and are unlikely to pay dividends in the immediate or near future. The likelihood of our
success must be considered in light of the problems, expenses, difficulties, complications and delays frequently encountered in connection
with the establishment of any business. An investment in our securities may result in the loss of an investor’s entire investment.
Only potential investors who are experienced in high-risk investments and who can afford to lose their entire investment should